Valve Regurgitation Diagnostic and Treatment Market: Snapshot
Any damage or defect in any one of the four heart valves can lead to a form of valve regurgitation disorders. Leakage or regurgitation in any of the heart’s valves, known as mitral, tricuspid, aortic, and pulmonary, can lead to severe disturbances in the human body and cardiac systems. This highlights the need for efficient and rapid testing equipment in the global valve regurgitation diagnostic and treatment market. Another factor stimulating the growth in the industry is the rising evolution and adoption of advanced cardiac surgical procedures for adult patients. Disorders relating to dysfunction or leakage of the heart valves can be treated by medications as well as surgeries in the global valve regurgitation diagnostic and treatment market.
Increasing preference for minimally invasive surgeries and endovascular and transcatheter valve therapies is also expected to bolster the growing global valve regurgitation diagnostic and treatment market in coming years. However, risky and highly sensitive nature of various heart surgeries and dearth of highly skilled and specifically specialized heart surgeons can impede the growth of the global valve regurgitation diagnostic and treatment market in years to come. Some of the key factors propelling the need for efficient and precise diagnostic and therapeutic solutions in the global valve regurgitation diagnostic and treatment market include rapidly changing and increasingly sedentary nature of modern lifestyles, increased levels of stress, and rising consumption of alcohol, all of which are some of the key causes for heart diseases.
Valve regurgitation is a structural heart disease. Regurgitation is the name for leaking heart valves. It happens when a heart's valve does not close tightly. In patients with valve regurgitation, blood cannot move properly in the rest of the body. Valve regurgitation can be caused by problems with the heart valve such as damaged tissue cords, rheumatic fever, abnormality of the heart muscle, congenital heart defects, radiation therapy, and atrial fibrillation. Some common symptoms associated with valve regurgitation are abnormal heart sound, fatigue, swollen feet or ankles, and shortness of breath (dyspnea). Major complications associated with valve regurgitation are atrial fibrillation, heart failure, and pulmonary hypertension. Several factors can increase the risk of valve regurgitation, including a history of mitral valve prolapse or mitral valve stenosis, heart attacks, and infections such as endocarditis or rheumatic fever.
Doctors can diagnose valve regurgitation based on medical history and tests. The common diagnostic tests for the condition are echocardiogram, chest X-ray, cardiac MRI, and cardiac catheterization. An electrocardiogram (ECG) can be used to detect enlarged chambers of the heart due to valve regurgitation.
A rise in the prevalence of valve regurgitation is anticipated to drive the global valve regurgitation diagnostic and treatment market during the forecast period. Increase in government prioritization of valve regurgitation treatment is also expected to propel the global valve regurgitation diagnostic and treatment market in the near future. However, a shortage of health care experts in cardiology in Latin America and Middle East & Africa is likely to hamper the valve regurgitation diagnostic and treatment market in these regions. Favorable reimbursement health care policy in North America and Europe are anticipated to propel the market in these regions during the forecast period.
The global valve regurgitation diagnostic and treatment market can be segmented based on type of regurgitation, diagnostic test, treatment procedure, end-user, and region. In terms of type of regurgitation, the valve regurgitation diagnostic and treatment market can be divided into mitral regurgitation, aortic valve regurgitation, pulmonary or pulmonic regurgitation, and tricuspid regurgitation. Based on treatment, the valve regurgitation diagnostic and treatment market can be classified into surgical repair treatment and replacement treatment. In terms of diagnosis, the market can be divided into echocardiogram, chest X-ray, cardiac MRI, cardiac catheterization, and others. Based on end-user, the global valve regurgitation diagnostic and treatment market can be categorized into hospitals, special clinics, and academic institutes & research organization. The hospitals segment held a significant share of the market in 2017.
Based on region, the global valve regurgitation diagnostic and treatment market can be segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America accounted for a major share of the global market in 2017, followed by Europe and Asia Pacific. The U.S. held a significant share of the market in North America in terms of revenue in 2017. The valve regurgitation diagnostic and treatment market in Asia Pacific is expanding rapidly, due to an increase in the number of patients suffering from valve regurgitation. Better health care infrastructure, economic growth, rise in the number of insurance payers, expanding & developing private health care sector, and increase in awareness among people about valve regurgitation diagnosis and treatment are expected to propel the market in the region in the next few years. The valve regurgitation diagnostic and treatment market in Latin America and Middle East & Africa is projected to expand at a moderate growth rate from 2018 to 2026.
Key players operating in the global valve regurgitation diagnostic and treatment market include Abbott, Boston Scientific Corporation, Braile Biomédica, CryoLife, Inc., Edwards Lifesciences Corporation, LivaNova plc, Lepu Medical Technology, Medtronic, Micro Interventional Devices, Inc., and TTK HealthCare.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
With a robust experience in creating exceptional market reports, Transparency Market Research has emerged as one of the trusted market research companies among a large number of stakeholders and CXOs. Every report at Transparency Market Research goes through rigorous research activity in every aspect. The researchers at TMR keep a close watch on the market and extract beneficial growth-boosting points. These points help the stakeholders to strategize their business plans accordingly.
TMR researchers conduct exhaustive qualitative and quantitative research. This research involves taking inputs from the experts in the market, focused attention on recent developments, and others. This method of research makes TMR stand out from other market research firms.
Here's how Transparency Market Research helps the stakeholders and CXOs through the reports:
Inculcation and Evaluation of Strategic Collaborations: The TMR researchers analyze recent strategic activities like mergers, acquisitions, partnerships, collaborations, and joint ventures. All the information is compiled and included in the report.
Perfect Market Size Estimations: The report analyzes the demographics, growth potential, and capability of the market through the forecast period. This factor leads to the estimation of the market size and also provides an outline about how the market will retrieve growth during the assessment period.
Investment Research: The report focuses on the ongoing and upcoming investment opportunities across a particular market. These developments make the stakeholders aware of the current investment scenario across the market.
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.